This excerpt taken from the PDGI 8-K filed Nov 30, 2006.
DAVID OLIVIER AND PER WOLD-OLSEN JOIN PHARMANET DEVELOPMENT GROUP BOARD OF DIRECTORS
Princeton, NJ November 27, 2006 PharmaNet Development Group, Inc. (NASDAQ: PDGI), a leading provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, today announced that David Olivier and Per Wold-Olsen have been appointed to the PharmaNet Development Group, Inc. Board of Directors.
We are pleased to have these two industry leaders join our board of directors, commented Jeffrey P. McMullen, president and chief executive officer. David and Per bring additional industry expertise and international perspective, complementing the other outstanding individuals who recently joined our board of directors.
Davids and Pers experience and career accomplishments bring valuable insight and resources to our existing team, commented Jack Levine, chairman of the board of directors. They complete the current additions to the board.
Mr. Olivier is currently chairman of Alterna, LLC, a company that acquires and markets over the counter pharmaceutical products, having retired from American Home Products Corporation (AHPC) in 2002. From 1996 through 2002, Mr. Olivier was senior vice-president of AHPC with responsibility for worldwide consumer products and corporate advertising and promotion. From 1988 to 1996, he was president of Wyeth-International, Inc. and was an elected member of the Executive Committee of AHPC. From 1986 to 1988, David was executive vice president and chief operating officer of AHPC's international pharmaceutical division.
Mr. Olivier served as president of Sherwood Medical Groups North American Division from 1984 to 1986. Sherwood was acquired in 1982 by American Home Products Corporation (renamed Wyeth Corporation in 2002). Previously, he served as Vice President of Marketing of Brunswick's Sherwood Medical Group from 1973 to 1984. Mr. Olivier began his career in corporate marketing with the Brunswick Corporation.
Mr. Wold-Olsen, who will reside in Europe, was with Merck and Co., Inc from 1973 to 2006, most recently as president, human health intercontinental and responsible for Europe, Eastern Europe, Middle East/Africa, India, Latin America and Canada regions. From 1997 to 2005, he served as president, human health Europe, Middle East/Africa and worldwide human health marketing and was a member of the Merck management committee from 1994 to 2006. From 1994 to 1997, he was president, human health Europe having previously served as senior vice president marketing, human health. From 1986 to 1991, he was a regional director for Scandinavia having held other leadership positions in Norway since 1973.